Document is current
Any future updates will be listed below
-
Authors
Fajol, Abul
Faul, Christian
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01DK125459 and R01HL145528)
- License Information
-
More Information
Article History
Received: 25 March 2025
Revised: 12 May 2025
Accepted: 23 May 2025
First Online: 5 June 2025
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: C.F. has served as consultant for Bayer and Calico Labs. C.F. is an inventor on two pending patents (PCT/US2019/049211; PCT/US19/49161), and he has a patent on FGFR inhibition (European Patent No. 2723391). C.F. is the co-founder and CSO of a startup biotech company (Alpha Young LLC). C.F. received honoraria for publishing a book (“FGF23”, Elsevier, ISBN9780128180365). A.F. declares that there is no competing interest.
: Not applicable.
